Yale SOM’s Jeffrey Sonnenfeld and author Joanne Lipman write that popular chatbots have proven susceptible to manipulation, ...

Jeffrey Sonnenfeld and coauthors write that Ukrainian President Volodymyr Zelenksy’s recent moves against political rivals are self-defeating and dangerous missteps. They argue that he needs to show ...

Meta has lured a string of top researchers from rivals with nine-figure pay packages in an effort to close the gap with AI leaders like OpenAI, Anthropic, and Google. But splashy hires rarely end up ...

Jeffrey Sonnenfeld and coauthors write that Ukrainian President Volodymyr Zelenksy’s recent moves against political rivals are self-defeating and dangerous missteps. They argue that he needs to show ...

More than 30 years ago, Jeffrey Rudolph ’78 developed a master plan to build the California Science Center into a center of ...

Yale SOM leadership expert Jeffrey Sonnenfeld and co-author Steven Tian argue that Cook’s unmatched track record makes him uniquely positioned to steer the company into its next phase of innovation ...

Diane Garnick, TIAA’s chief income strategist, says that on average, women don’t accumulate as much in retirement savings as men do. She talked to Yale Insights about why this gap exists, and how ...

In this special episode, Howie and Harlan are joined by Vivek Murthy, the 19th and 21st Surgeon General of the United States, and a graduate of the Yale School of Management and the Yale School of ...

This commentary originally appeared in Fortune. The views expressed are the authors’ own. We have presciently warned for a year, and earlier this week in Fortune, that Trump’s economic policies and ...

The success of India’s Aadhaar, a biometrically secured national identification system, has ignited a debate over whether any entity, public or private, should have the ability to pool our full ...

Howie and Harlan are joined by Ania Jastreboff, a Yale endocrinologist and an expert on obesity medication, to talk about the remarkable range of diseases treated by drugs like Ozempic, Mounjaro, and ...